HealthcarePsyence Biomedical to acquire drug developer ClairvoyantBy Helitra.com·September 7, 2024·1 min read Psyence Biomedical to acquire drug developer Clairvoyant Source: SeekingalphaADVERTISEMENT ADVERTISEMENTacquire Biomedical Clairvoyant developer drug Psyence Post navigation Previous storyAfya announces MEC decision on medical seats reconsiderationNext storyOrganon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma
Fitness · HealthcareExercise Physiologist Warns This Classic Stretch Before Cold-Weather Workouts Temporarily Cuts Strength by Up to 7.5%November 17, 2026For years, the fitness world has been debating what actually counts as a proper warmup before a workout. Should you sit on the…
Fitness · HealthcareToday’s Cannabis Is Not the Mild Plant That People Remember From the PastNovember 17, 2026Since 2012, when the first states legalized recreational cannabis, the United States has conducted one of the largest drug-policy experiments in its history.…
Fitness · HealthcareIf You Are on GLP-1 Drugs, You Must Lift Weights to Keep Your Muscle MassNovember 17, 2026For most of the past half century, a successful outcome meant a smaller number on the scale.That has changed. GLP-1 and dual-agonist medications…